Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Nov 8, 2016 · 10-Q · 39 days after period end · 0001193125-16-763038
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$48.51M | -$22.67M | -$19.19M | -$12.87M |
| EPS Diluted | -$1.24 | -$0.63 | -$0.66 | -$0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 8, 2016 · 39 d after period end
